CVS Health Corp
CVS: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|W^ | LOCK|YS | LOCK|Xqf%D!m |
CVS Health Earnings: Aetna Margin Improvement Boosts 2026 Outlook and Fair Value
CVS reported second-quarter results including 7% revenue growth and over 40% adjusted earnings per share growth to $2.58, or above FactSet consensus of $1.85. On these stronger-than-expected results, management raised its 2026 outlook. It also gave initial 2027 commentary.
